Cancer incidence attributable to tobacco in Alberta, Canada, in 2012
- PMID: 28018870
- PMCID: PMC5173469
- DOI: 10.9778/cmajo.20150069
Cancer incidence attributable to tobacco in Alberta, Canada, in 2012
Abstract
Background: Strong and consistent epidemiologic evidence shows that tobacco smoking causes cancers at various sites. The purpose of this study was to quantify the proportion and total number of site-specific cancers in Alberta attributable to tobacco exposure.
Methods: The proportion of incident cancer cases attributable to active and passive tobacco exposure in Alberta was estimated with population attributable risks. Data from the Canadian Community Health Survey (CCHS) for 2000-2007 were used to estimate prevalence of active (current or former smoker) and passive (second-hand smoke) tobacco exposure in Alberta.
Results: According to the 2000/01 CCHS, 29.1% and 38.6% of Albertans were estimated to be current and former smokers, respectively. According to the 2003 CCHS, 23.7% of Albertans who had never smoked reported regular second-hand exposure to tobacco. Population attributable risk estimates for tobacco-related cancer sites ranged from about 4% for ovarian cancer to 74% for laryngeal cancer. About 5% of incident lung cancers in men and women who never smoked could be attributed to passive tobacco exposure. Overall, 37.0% of tobacco-related cancers in Alberta (or 15.7% of all cancers) were estimated to be attributable to active tobacco smoking in 2012.
Interpretation: A notable proportion of cancers associated with tobacco use were estimated to be attributable to active smoking in Alberta. Strategies to reduce the prevalence of active tobacco smoking in Alberta could have a considerable impact on future cancer incidence.
Conflict of interest statement
Conflicts of Interest: None declared.
Similar articles
-
Estimates of the current and future burden of cancer attributable to active and passive tobacco smoking in Canada.Prev Med. 2019 May;122:9-19. doi: 10.1016/j.ypmed.2019.03.015. Prev Med. 2019. PMID: 31078177
-
Cancer incidence attributable to excess body weight in Alberta in 2012.CMAJ Open. 2017 Apr 28;5(2):E330-E336. doi: 10.9778/cmajo.20160039. CMAJ Open. 2017. PMID: 28455439 Free PMC article.
-
Lung cancer incidence attributable to residential radon exposure in Alberta in 2012.CMAJ Open. 2017 Jun 28;5(2):E529-E534. doi: 10.9778/cmajo.20160053. CMAJ Open. 2017. PMID: 28663187 Free PMC article.
-
Passive smoking and the risk of heart disease.JAMA. 1992 Jan 1;267(1):94-9. JAMA. 1992. PMID: 1727204 Review.
-
Avoidable cancers in the Nordic countries. Tobacco smoking.APMIS Suppl. 1997;76:9-47. APMIS Suppl. 1997. PMID: 9462818 Review.
Cited by
-
Cancer incidence attributable to tobacco smoking in GCC countries in 2018.Tob Induc Dis. 2020 Mar 19;18:18. doi: 10.18332/tid/118722. eCollection 2020. Tob Induc Dis. 2020. PMID: 32256282 Free PMC article.
-
The Cancer Prevention Project of Philadelphia: preliminary findings examining diversity among the African diaspora.Ethn Health. 2021 Jul;26(5):659-675. doi: 10.1080/13557858.2018.1548695. Epub 2018 Nov 19. Ethn Health. 2021. PMID: 30453751 Free PMC article.
-
Regional differences in tobacco smoking and lung cancer in Portugal in 2018: a population-based analysis using nationwide incidence and mortality data.BMJ Open. 2020 Oct 23;10(10):e038937. doi: 10.1136/bmjopen-2020-038937. BMJ Open. 2020. PMID: 33099497 Free PMC article.
-
Preventable causes of cancer in Texas by race/ethnicity: tobacco smoking.Epidemiol Health. 2021;43:e2021046. doi: 10.4178/epih.e2021046. Epub 2021 Jul 13. Epidemiol Health. 2021. PMID: 34265892 Free PMC article.
-
Cancer incidence attributable to lifestyle and environmental factors in Alberta in 2012: summary of results.CMAJ Open. 2017 Jul 7;5(3):E540-E545. doi: 10.9778/cmajo.20160045. CMAJ Open. 2017. PMID: 28687643 Free PMC article.
References
-
- Taylor R, Najafi F, Dobson A. Meta-analysis of studies of passive smoking and lung cancer: effects of study type and continent. Int J Epidemiol. 2007;36:1048–59. - PubMed
-
- Boffetta P, Clark S, Shen M, et al. Serum cotinine level as predictor of lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2006;15:1184–8. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources